Found 170 matching trials
Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir
PHASE2The HIV epidemic represents one of the greatest health challenges worldwide...
Location
Hospital Universitario Ramón y Cajal
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
PHASE2Maraviroc (MVC) is a type of HIV medicine called a CCR5 inhibitor. This stu...
Location
UAB HIVTR-CCR5 Non-Network CRS
A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects
PHASE4An open label study to evaluate an interaction between maraviroc and ralteg...
Location
Pfizer Investigational Site
Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1
PHASE2The presence of a pool of cells latently infected by HIV-1 in patients taki...
Location
Hospital Universitario Ramon Y Cajal
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
PHASE2The goal of this clinical study is to learn more about the effects of switc...
Status
Active Not Recruiting
Location
Be Well Medical Center
CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery
PHASE4CCTG 590 is a open-label study to evaluate the impact of therapy intensific...
Location
University Southern California
Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
PHASE2The objective of this study is to discover a new approach in which human im...
Location
University of California San Francisco
Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)
PHASE2Maraviroc (MVC) is a drug, very well tolerated, it has been seen that MVC h...
Location
Hospital Universitario Virgen del Rocio
Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring
PHASE1The purpose of this study is to assess the pharmacokinetics of the combinat...
Location
University of Alabama at Birmingham
Expanded Access Program for Maraviroc At Multiple Centers
PHASE3To provide access to maraviroc to patients who have limited or no therapeut...
Location
The University of Alabama